Radiotherapie et degenerescence maculaire liee a l'age: Revue de la litterature;Radiation therapy in the treatment of macular degeneration: A review

Cancer/Radiotherapie

Volumn 1, Issue 3, 1997, Pages 208-212

  Schwartz, L H ^a   Schmitt, T ^b   Benchaboun, M ^b   Caputo, G ^c   Chauvaud, D ^c   Balosso, J ^d   Faivre, C ^d   Francais C ^e   Koenig, F ^b  

^a SAINT LOUIS HOSPITAL   (France)

^b SERVICE DE NEUROLOGIE   (France)

^c HÔTEL DIEU   (France)

^d HÔPITAL TENON   (France)

^e HÔPITAL SAINT ANTOINE   (France)

Author keywords

Age related macular degeneration; Radiotherapy

Indexed keywords

HUMAN; LASER; NEOVASCULARIZATION (PATHOLOGY); PRIORITY JOURNAL; RADIATION DOSE; RETINA MACULA DEGENERATION; REVIEW; VISUAL ACUITY; AGED; AGING; CLINICAL TRIAL; MULTICENTER STUDY; PATHOPHYSIOLOGY; PILOT STUDY; RETINA DISEASE; TREATMENT OUTCOME;

AGED; AGING; HUMANS; MACULAR DEGENERATION; NEOVASCULARIZATION, PATHOLOGIC; PILOT PROJECTS; RADIOTHERAPY DOSAGE; RETINAL DISEASES; TREATMENT OUTCOME;

EID: 0030634057     PISSN: 12783218     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1278-3218(97)89766-1     Document Type: Review

References (38)

1. Amoaku WMK, Frew L, Mahon GJ, Gardiner TA, Archer DB. Early ultrastructural changes after low-dose X-irradiation in the retina of the rat. Eye 1989;3:638-46
2. Amoaku WMK, Mahon GJ, Gardiner TA, Frew L, Archer DB. Late ultrastructural changes in the retina of the rat following low-dose X-irradiation. Graefe's Arch Clin Exp Ophtalmol 1992;230:569-74
3. Archer DB, Gardiner TA. Ionizing radiation and the retina. Curr Op Ophtalmol 1994;5:59-65
4. Bergink GJ, Deutman AF, Van Den Broek JFCM, Van Da WAJ, Van Der Maazen RWN. Radiation therapy for subfoveal choroidal neovascular membranes in age-related macular degeneration. A pilot study. Doc Ophtalmol 1995;90:67-74
5. Bressler NM, Bressler SB, Fine SL. Age-related macular degeneration. Survey Ophtalmol 1988;32:375-413
6. Bressler NM, Frost LA, Bressler SB, Murphy RP, Fine SL. Natural course of poorly defined choroidal neovascularization associated with macular degeneration. Arch Ophtalmol 1988;106:1537-42
7. Brown GC, Shields JA, Sanborn G, Augsburger JJ, Savino PJ, Schatz NJ. Radiation optic neuropathy. Ophtalmol 1982;89:1489-93
8. Caputo G, Chuart L. Radiothérapie externe dans la DMLA exsudative. Société Française d'Ophtalmologie. Paris 12-16 mai 1996
9. Chakravarthy U, Biggart JH, Gardiner TA, Archer DB, Maguire CJF. Focal irradiation of perforating eye injuries: minimum effective dose and optimum time of irradiation. Cur Eye Res 1989;8:1241-50
10. Chakravarthy U, Houston RF, Archer DB. Treatment of age-related neovascular membranes by teletherapy: a pilot study. Br J Ophtalmol 1993;77:265-73
11. Coscas G. Dégénérescences maculaires acquises liées à l'âge et néovaisseaux sous-rétiniens. Société Française d'Ophtalmologie. Paris: Masson; 1991
12. Coscas G, Soubrane G. Photocoagulation des néovaisseaux sousrétiniens dans la dégénérescence maculaire sénile par laser à argon: résultats de l'étude randomisée de 60 cas. Bull Mém Soc Fr 1983;88:102-6
13. d'Amato RJ, Adamis AP. Angiogenesis inhibition in age-related macular degeneration. Ophtalmology 1995;102:1261-2
14. Eye Disease Control Study Group. Risk factors for neovascular age-related macular degeneration. Arch Ophtalmol 1992;110:1701-8
15. Ferris FL III. Senile macular degeneration: Review of epidemiologic features. Am J Epidemiol 1983;118:132-51
16. Ferris FL III, Fine SL, Hyman LA. Age-related macular degeneration and blindness due to neovascular maculopathy. Arch Ophtalmol 1984;102:1640-2
17. Fung We. Interferon alpha-2a for treatment of age-related macular degeneration. Am J Ophtalmol 1991;112:349-50
18. Gibson JM, Lavery JR, Rosenthal AR. Blindness and partial sight in an elderly population. Br J Ophtalmol 1986;70:700-5
19. Glaser BM, Campochiaro PA, Davis JL, Sato M. Retinal pigment epithelial cells release an inhibitor of neovascularization. Arch Ophtalmol 1986;70:700-5
20. Hart PM, Archer DB, Chakravarthy U. Asymmetry of disciform scarring in bilateral disease when one eye is treated with radiotherapy. Br J Ophtalmol 1995;79:562-8
21. Johnson LK, Longenecker JP, Fajardo LF. Differential radiation response of cultured endothelial cells and smooth myocytes. Anal Quant Cytol 1992;4:188-98
22. Klein R, Klein BEK, Linton KLP, De Mets DL. Beaver Dam Eye Study: visual acuity. Ophtalmology 199;98:1310-5
23. Klein R, Klein BEK, Linton KLP. Prevalence of age-related maculopathy: the Beaver Dam eye study. Ophtalmology 1992;99:933-43
24. Koenig F, Soubrane G, Coscas G. Aspects angiographiques de la dégénérescence maculaire senile. J Fr Ophtalmol 1984;7:93-8
25. Koenig F, Schmitt T, Goyet D, Puel G, Favrel V. Electrontherapy for macular lesions. Frontiers of radiation therapy and oncology. Hinkelbein and Budach 1996; (in press)
26. Leibowitz H, Krueger DE, Maunder LR, Milton R, Kini MM, Kahn HA, Micherson RJ, Pool J, Colton T, Ganley JP. The Framingham eye study monograph. Surv Ophtalmol 1980;24:335-610
27. Macular Photocoagulation Study Group. Subfoveal neovascular lesions in age-related macular degeneration; guidelines for evaluation and treatment in the macular photocoagulation study. Arch Ophtalmol 1991;109:1242-57
28. Macular Photocoagulation Study Group. Argon laser photocoagulation for neovascular maculopathy. Five years results from randomized clinical trials. Arch Ophtalmol 1991;109:1109-14
29. Macular Photocoagulation Study Group. Argon laser photocoagulation for senile macular degeneration results of a randomized clinical trial. Arch Ophtalmol 1982;100:912-8
30. Macular Photocoagulation Study Group. Persistent and recurrent neovascularization after krypton laser photocoagulation for neovascular lesions of age-related macular degeneration. Arch Ophtalmol 1990;108:825-31
31. Merriam GR, Szechter A, Focht EF. The effects of ionizing radiations on the eye. Front Radiat Ther Oncol 1972;6:346-82
32. Moorfields macular study group. Treatment of senile macular degeneration: a single blind randomized trial by argon laser photocoagulation. Br J Ophtalmol 1982;60:745-53
33. Ryan SJ. Subretinal neovascularizanon: natural history of an experimental model. Arch Ophtalmol 1982;100:1804-9
34. Sagerman RH, Chung CT, Albert WE. Radiosensitivity of ocular and orbital structures. In: Alberti and Sagerman, eds. Radiotherapy of intraocular and orbital tumors. Springer-Verlag 1994;38:375-85
35. Soubrane G, Coscas G, Français C, Koenig F. Occult subretinal new vessels in age-related macular degeneration. Natural history and early laser treatment. Ophtalmology 1990;97:649-57
36. Thomas MA, Ibanez HE. Interferon alpha-2a in the treatment of subfoveal choroidal neovascularization. Am J Ophtalmol 1993;115:563-8
37. Vingerling JR, Dielemans I, Hofman A, Grobbee DE, Hijmering M, Kramer CFL, de Jong PTVM. The prevalence of age-related maculopathy in the Rotterdam study. Ophtalmol 1995;102:205-10
38. Yannuzzi LA. A new standard of care for laser photocoagulation of subfoveal choroidal neovascularization secondary to age-related macular degeneration. Arch Ophtalmol 1994;112: 462-4